Matches in Wikidata for { <http://www.wikidata.org/entity/Q89515747> ?p ?o ?g. }
Showing items 1 to 56 of
56
with 100 items per page.
- Q89515747 description "article scientifique publié en 2020" @default.
- Q89515747 description "articolo scientifico (pubblicato il 2020)" @default.
- Q89515747 description "artikull shkencor i botuar më 01 shkurt 2020" @default.
- Q89515747 description "artículu científicu espublizáu en febreru de 2020" @default.
- Q89515747 description "im Februar 2020 veröffentlichter wissenschaftlicher Artikel" @default.
- Q89515747 description "scientific article published on 01 February 2020" @default.
- Q89515747 description "wetenschappelijk artikel" @default.
- Q89515747 description "наукова стаття, опублікована 1 лютого 2020" @default.
- Q89515747 name "Adverse event rate during inpatient sotalol initiation for the management of supraventricular and ventricular tachycardia in the pediatric and young adult population" @default.
- Q89515747 name "Adverse event rate during inpatient sotalol initiation for the management of supraventricular and ventricular tachycardia in the pediatric and young adult population" @default.
- Q89515747 name "Adverse event rate during inpatient sotalol initiation for the management of supraventricular and ventricular tachycardia in the pediatric and young adult population" @default.
- Q89515747 type Item @default.
- Q89515747 label "Adverse event rate during inpatient sotalol initiation for the management of supraventricular and ventricular tachycardia in the pediatric and young adult population" @default.
- Q89515747 label "Adverse event rate during inpatient sotalol initiation for the management of supraventricular and ventricular tachycardia in the pediatric and young adult population" @default.
- Q89515747 label "Adverse event rate during inpatient sotalol initiation for the management of supraventricular and ventricular tachycardia in the pediatric and young adult population" @default.
- Q89515747 prefLabel "Adverse event rate during inpatient sotalol initiation for the management of supraventricular and ventricular tachycardia in the pediatric and young adult population" @default.
- Q89515747 prefLabel "Adverse event rate during inpatient sotalol initiation for the management of supraventricular and ventricular tachycardia in the pediatric and young adult population" @default.
- Q89515747 prefLabel "Adverse event rate during inpatient sotalol initiation for the management of supraventricular and ventricular tachycardia in the pediatric and young adult population" @default.
- Q89515747 P1433 Q89515747-3749AAA7-3271-4D62-9A45-D6320833C775 @default.
- Q89515747 P1476 Q89515747-5A6FCE72-B156-4AEF-B1AA-73E55E9850EA @default.
- Q89515747 P2093 Q89515747-0B2A2F00-ABBF-4660-957E-79482DFA9F28 @default.
- Q89515747 P2093 Q89515747-131E9A95-CAE7-4331-B0BB-B1FB7AF0C3FE @default.
- Q89515747 P2093 Q89515747-13461893-1886-445E-BC87-5BFD15F67F6A @default.
- Q89515747 P2093 Q89515747-3D2F3DBA-9B93-400A-A1C9-3935F2BEDBA4 @default.
- Q89515747 P2093 Q89515747-45A673BC-97E9-4769-8A77-C399E1EA188A @default.
- Q89515747 P2093 Q89515747-4BA82BB2-AC9D-42CF-9A96-7D4A515444A1 @default.
- Q89515747 P2093 Q89515747-5FC409AC-BFA8-4D2F-8CEC-45122FD63F9A @default.
- Q89515747 P2093 Q89515747-6547BACC-1AB6-4CBD-8F42-CCF5FB5D1206 @default.
- Q89515747 P2093 Q89515747-AF508B02-293B-4F90-96CE-B30CF73FC168 @default.
- Q89515747 P2093 Q89515747-C7A45311-D6F2-41DC-BB96-2F780970401B @default.
- Q89515747 P2093 Q89515747-E5A6E9B0-8E17-4B32-897C-C79B2963E441 @default.
- Q89515747 P31 Q89515747-34477E7D-E2E0-44A1-ABC9-FB4B56AA80E6 @default.
- Q89515747 P356 Q89515747-5CF2EC17-A76C-4A7A-B33F-192F8E0F8DBB @default.
- Q89515747 P577 Q89515747-84B599D4-B3E6-41E4-936F-D7B78DF4F128 @default.
- Q89515747 P698 Q89515747-3A473541-A6F0-426C-BA20-A96391E83CB0 @default.
- Q89515747 P921 Q89515747-EABE1D54-2F33-4706-A39B-6C24F4FDDD4D @default.
- Q89515747 P356 J.HRTHM.2020.01.022 @default.
- Q89515747 P698 32014568 @default.
- Q89515747 P1433 Q2058605 @default.
- Q89515747 P1476 "Adverse event rate during inpatient sotalol initiation for the management of supraventricular and ventricular tachycardia in the pediatric and young adult population" @default.
- Q89515747 P2093 "Dominic J Abrams" @default.
- Q89515747 P2093 "Douglas Y Mah" @default.
- Q89515747 P2093 "Edward P Walsh" @default.
- Q89515747 P2093 "Elizabeth S DeWitt" @default.
- Q89515747 P2093 "Esther Chu" @default.
- Q89515747 P2093 "John K Triedman" @default.
- Q89515747 P2093 "Laura M Bevilacqua" @default.
- Q89515747 P2093 "Mark E Alexander" @default.
- Q89515747 P2093 "Robert D Whitehill" @default.
- Q89515747 P2093 "Stephanie F Chandler" @default.
- Q89515747 P2093 "Vassilios J Bezzerides" @default.
- Q89515747 P31 Q13442814 @default.
- Q89515747 P356 "10.1016/J.HRTHM.2020.01.022" @default.
- Q89515747 P577 "2020-02-01T00:00:00Z" @default.
- Q89515747 P698 "32014568" @default.
- Q89515747 P921 Q56002 @default.